Goldman Sachs’s Imperva, Inc. IMPV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-200
Closed -$8K 6618
2017
Q4
$8K Sell
200
-34,800
-99% -$1.45M ﹤0.01% 6224
2017
Q3
$1.52M Buy
35,000
+28,600
+447% +$1.31M ﹤0.01% 4222
2017
Q2
$306K Sell
6,400
-1,300
-17% -$60.6K ﹤0.01% 5489
2017
Q1
$316K Sell
7,700
-10,900
-59% -$455K ﹤0.01% 5424
2016
Q4
$714K Sell
18,600
-9,700
-34% -$394K ﹤0.01% 4747
2016
Q3
$1.52M Buy
28,300
+18,600
+192% +$863K ﹤0.01% 4043
2016
Q2
$417K Buy
9,700
+7,200
+288% +$302K ﹤0.01% 5029
2016
Q1
$126K Buy
2,500
+900
+56% +$43.3K ﹤0.01% 5939
2015
Q4
$101K Sell
1,600
-4,900
-75% -$334K ﹤0.01% 6172
2015
Q3
$426K Buy
6,500
+1,200
+23% +$79.6K ﹤0.01% 5310
2015
Q2
$359K Sell
5,300
-10,400
-66% -$574K ﹤0.01% 5553
2015
Q1
$670K Buy
15,700
+4,000
+34% +$178K ﹤0.01% 4846
2014
Q4
$578K Buy
11,700
+3,400
+41% +$136K ﹤0.01% 5151
2014
Q3
$238K Sell
8,300
-24,400
-75% -$663K ﹤0.01% 5993
2014
Q2
$856K Buy
32,700
+24,400
+294% +$630K ﹤0.01% 4834
2014
Q1
$462K Sell
8,300
-3,100
-27% -$178K ﹤0.01% 5354
2013
Q4
$549K Sell
11,400
-200
-2% -$8.41K ﹤0.01% 5230
2013
Q3
$487K Sell
11,600
-3,800
-25% -$181K ﹤0.01% 5170
2013
Q2
$694K Buy
+15,400
New +$604K ﹤0.01% 4684

Goldman Sachs's IMPV Position: Q1 2019 in Review

Goldman Sachs sold out of Imperva, Inc. (IMPV) in Q1 2019, closing a stake of 1,602,636 shares — an estimated $89.3M sold.

Goldman Sachs first reported a position in IMPV in Q2 2013 and held it in 23 quarters. The position peaked at $89.3M in Q4 2018. 0 funds tracked by Wall St. Rank hold IMPV as of Q1 2019.

  • Goldman Sachs reported no remaining Imperva, Inc. position as of Q1 2019 after selling out during the quarter.
  • Goldman Sachs sold 1,602,636 Imperva, Inc. shares in Q1 2019, an estimated $89.3M.
  • Goldman Sachs first reported a position in Imperva, Inc. in Q2 2013 and held it in 23 quarters.
  • Goldman Sachs's Imperva, Inc. position peaked at $89.3M in Q4 2018.
  • 0 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2019.

Based on Goldman Sachs's 13F filing for Q1 2019, filed 15 May 2019.